PARTNER 3: TAVR Associated with Better Health Status At 12 Months As Compared to SAVR in Patients with Severe Aortic Stenosis and Low Surgical Risk
Findings from the ongoing PARTNER 3 trial were published in the Journal…
REMEDIAL III: Urine Flow Rate Guided Hydration Is Superior to Left Ventricular End‐Diastolic Pressure Guided Hydration for Preventing Renal And/Or Pulmonary Edema in Interventional Cardiology
Findings of an ongoing REMEDIAL (REnal Insufficiency Following Contrast MEDIA Administration triaL)…
EXCEL Trial: Five-Year Data Suggests PCI Non-Inferior to CABG in Patients with Left Main Coronary Artery Disease
The results of a randomized controlled trial led by Dr. Gregg W.…
The COMPLETE Timing Substudy: A Randomized Trial of Complete Staged Revascularization Vs. Infarct Artery PCI Alone in Patients With Acute Myocardial Infarction and Multivessel Disease – Importance of Revascularization Timing
The results of a substudy of the COMPLETE Trial were presented at…
AUGUSTUS Trial: Dual Therapy with P2Y12 Inhibitor and Apixaban Safer Than Triple Therapy or Dual Therapy with Warfarin in Patients with Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
The results of a randomized controlled trial led by Dr. Renato Lopes…
New 1,500 Patient Study Demonstrates Favorable 1-Year Mortality Rate in Mitral Valve-In-Valve Implantation in Patients With Failed Mitral Valve Surgery
The results of a combined analysis of the STS/ACC/TVT Registry and the…
SCOPE I: ACURATE Neo (Self-Expanding TAVR System) Struggles to Have An Edge On SAPIEN 3 (Balloon-Expandable TAVR System)
Results of a randomized trial presented at TCT 2019 and simultaneously published…
Novel Subcutaneously Administered GpIIb/IIIa Inhibitor (RUC-4) Exhibits Promising Potential As The First Point-of-Contact Therapy of STEMI
Results of a new ongoing phase 1 study, presented at Transcatheter Cardiovascular…
Dual Anti-thrombotic Therapy Safe For Patients with Atrial Fibrillation and Recent PCI:ENTRUST-AF PCI
Results from a phase-IIIb, open-label, multi-center, randomized clinical trial comparing the safety…
STOPDAPT-2 Explores Safety and Efficacy of 1-month DAPT Followed by Clopidogrel Monotherapy vs Standard 12-month DAPT After Drug-Eluting Stent Implantation
The results of the STOP-DAPT 2 randomized controlled trial were presented by…
Dapagliflozin and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Prior MI
According to a presentation by Dr. Marc P. Bonaca at the American…
TAVR Using Balloon Expandable Valve Superior To Surgical Aortic Valve Replacement In Low Risk Patients With Severe Aortic Valve Stenosis
A randomized multi-center trial which enrolled 1000 patients from 71 centers around…
TREAT Trial Addresses the Safety and Efficacy of Ticagrelor Use for STEMI Management in the Setting of Fibrinolytic Therapy
According to the results of the TREAT trial, among patients aged under…
Total Event Analysis from REDUCE-IT Showcases a Substantial Reduction in the Burden of Ischemic Events, Experts Debate Possible Mechanisms of Action of Icosapent Ethyl
The total event analysis from the REDUCE-IT trial, presented at ACC 2019…
AUGUSTUS: Less Bleeding and Fewer Hospitalizations Without Significant Differences in Ischemic Events With Apixaban and No Aspirin in Patients With AFib and ACS
ACC 2019: In patients with atrial fibrillation and a recent acute coronary…
HeartMate3 Found to be More Superior Than Other LVADs on Endpoints of Stroke, Pump Thrombosis and Bleeding Complications
The largest LVAD trial ever to be performed, led by Dr. Mandeep…
COAPT Analysis Affirms Quality of Life Advantage of MitraClip for Secondary MR
NEW ORLEANS -- Transcatheter repair of functional mitral regurgitation (or secondary MR)…
HEARTLINE: A 180,000 Patient-Strong, Pragmatic, Real World Randomized Trial Assesses the Prowess of Apple Technology in Afib Diagnosis and Improvement of Hard Outcomes
The design of the HEARTLINE randomized trial of up to 180,000 pts…
Findings From a Randomized Controlled Trial May Usher the Adoption of Angiotensin–Neprilysin Inhibition to the Heart-Failure Armamentarium
The results of a trial presented by Dr. Adam DeVore at the…
ALERTS: Use of an Implanted Electrocardiographic Monitoring Device in High-Risk Patients Aids in the Early Detection of ACS
According to a randomized controlled trial led by Dr. Michael Gibson, PERFUSE…